Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June. 

Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year…

Boehringer Ingelheim has launched Care and Connect a free online PPID aftercare service for horse owners, designed to help veterinary practices monitor their PPID case load and streamline the case management process.

The new service is part of Boehringer…

Boehringer Ingelheim has rebranded its equine joint supplement, Seraquin GLME, as Equitop GLME.

Equitop GLME is a palatable, pearl formulation joint supplement developed to support the healthy function of cartilage, joint capsules, tendons and ligaments…

Boehringer Ingelheim has launched Aservo EquiHaler (ciclesonide inhalation solution), the first inhaled treatment for equine asthma.

The company says the new product has been 10 years in development and uses 'Soft Mist' technology - developed originally…

Boehringer Ingelheim has launched a recycling programme for Aservo EquiHaler, its treatment for equine asthma symptoms.

The company points to research which found that 89% of the veterinary profession wants to play a more active role in the sustainability…

Boehringer Ingelheim has received UK marketing authorisation for RenuTend - the first licensed treatment to improve healing of tendon injuries and suspensory ligaments in horses.

Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer says…